Edit search
The 76-gene signature defines high-risk patients that benefi…
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
Article, Chapter
Authors: Y. Zhang
Publication: Breast Cancer Research and Treatment, Volume:116, Issue:2, Page(s):-309
Published: Springer US, 2009
ISSN: 0167-6806
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item